Regulatory and Strategic solutions
for healthcare products
from Preclinical to Commercialization
EMA’s Feedback after 2 years of PRIME Procedure
The PRIME Procedure is a scheme launched by the European Medicines Agency (EMA) to enhance support for the development of… Read more >
Hélène Rouquette
President
IDD, A SOURCE OF IDEAS AT EVERY STAGE IN THE DEVELOPMENT PROCESS AND LIFECYCLE MANAGEMENT
IDD is a consulting firm specialized in Regulatory Affairs and Drug Development Strategy, focusing on two complementary areas of expertise:
With our project teams and our network of experts, we mobilize all our internal and external resources to support your projects at every stage of the development process from non-clinical and clinical development to Marketing Authorization submission and lifecycle management.
IDD EXPERTISE
Global Regulatory strategy from Preclinical to commercialization
Product development strategy and Project management
- Define target product profile
- Design CMC, non-clinical and clinical development plans
- Manage Development studies
- Organize Scientific Advice with regulators, Pre-IND meetings
- Conduct Registration procedure
Operational regulatory support and lifecycle management
- Due diligence and Audits of dossiers
- Management of variations / Product information
- Regulatory updates
- Pharmacovigilance
- Support quality management process (PQR, Regulatory monitoring…)
- Reimbursement strategy
Communication with the Authorities
- Facilitate relationships with regional and local Health Authorities (National, EMA, FDA, export…)
- Support registration procedure and follow-up commitments with the key Regulatory Agencies in EU/US/Export
- Organize regulatory advice for the development program and the regulatory strategy
- Market access (HTA…)